36 studies found for:    weill AND genetic medicine | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
Conditions: Peanut Allergy;   Allergic/Atopic Individuals;   Non Allergic Individuals;   Allergic Individuals Receiving Xolair Therapy
Intervention:
2 Recruiting Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis
Conditions: Batten Disease;   Late Infantile Neuronal Lipofuscinosis
Intervention:
3 Recruiting HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
Conditions: HIV;   COPD;   Emphysema;   Smoking
Intervention: Genetic: Genetic: Examination of the interaction of HIV directly on the small airway epithelium
4 Recruiting Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Asthma;   Smoking;   Smoking Cessation;   Healthy Smoker
Intervention:
5 Recruiting Alternate Nicotine Delivery Systems and Airway Epithelial Biology
Conditions: Smoking;   Smoking Cessation
Intervention:
6 Recruiting HIV-related Accelerated Aging of the Airway Epithelium
Conditions: HIV;   COPD;   Chronic Obstructive Pulmonary Disease;   Smoking
Intervention: Genetic: Examination of the interaction of HIV directly on the small airway epithelium
7 Recruiting Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.
Condition: Human Lung Diseases That Involves the Mediastinal Lymph Node.
Intervention:
8 Recruiting Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
Conditions: COPD;   Cigarette Smoke;   Smokers;   Nonsmokers
Intervention:
9 Recruiting Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Conditions: Batten Disease;   Late Infantile Neuronal Lipofuscinosis
Intervention: Genetic: AAVrh.10CUhCLN2 vector
10 Recruiting AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis With Uncommon Genotypes or Moderate/Severe Impairment
Conditions: Late Infantile Neuronal Ceroid Lipofuscinosis;   Batten Disease
Intervention: Biological: AAVrh.10CUCLN2
11 Recruiting International Study to Predict Optimised Treatment - in Depression
Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram;   Drug: Sertraline;   Drug: Venlafaxine XR
12 Not yet recruiting Safety Study of Gene Transfer Vector to Treat alpha1-antitrypsin Deficiency
Condition: alpha1-antitrypsin Deficiency
Intervention: Genetic: AAVrh.10halpha1AT
13 Unknown  Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Condition: Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferasirox
14 Recruiting Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Erlotinib
15 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation
16 Unknown  Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Condition: Prader-willi Syndrome
Interventions: Drug: rimonabant;   Drug: placebo
17 Recruiting Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
Condition: KRAS Mutant Metastatic Colorectal Cancer
Interventions: Biological: REOLYSIN®;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: Fluorouracil (5-FU);   Drug: Bevacizumab
18 Recruiting Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
Condition: Posttraumatic Stress Disorder
Interventions: Drug: DCS;   Other: Placebo
19 Recruiting Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Idiopathic Myelofibrosis
Intervention:
20 Not yet recruiting The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study
Condition: Thalassemia Major
Interventions: Drug: Vitamin D3;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
Indicates status has not been verified in more than two years